|
CA3038845A1
|
|
Methods for treating ocular diseases
|
|
TW201912176A
|
|
Composition for enhancing immunity of insects and method thereof
|
|
AU2016223994A1
|
|
Compounds for treating ocular diseases
|
|
KR20200096664A
|
|
Extract of taiwanese propolis for treating ocular diseases
|
|
TW201521749A
|
|
Composition for liver protection
|
|
JP2015189681A
|
|
Prenylflavanone compounds for modulating diabetes
|
|
US2014296543A1
|
|
Prenylflavanone compounds for modulating diabetes
|
|
CN102885854A
|
|
Taiwanese green propolis extractants used for the purpose of slowing down progression of disease of patient
|
|
TW201304789A
|
|
Use of taiwanese green propolis for slowing the progression of the disease of a patient
|
|
US2011054014A1
|
|
Prenylflavanone compounds and uses thereof
|
|
KR20110009611A
|
|
New use of histone deacetylase inhibitors in changing mrjp3 protein in royal jelly
|
|
TW201103899A
|
|
New use of histone deacetylase inhibitors in changing mrjp3 protein in royal jelly
|
|
EP2277387A1
|
|
New use of histone deacetylase inhibitors in changing mrjp3 protein in royal jelly
|
|
US2010256401A1
|
|
Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
|
|
EP2236503A1
|
|
Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
|
|
TW201019934A
|
|
Prenylflavanone compounds and uses thereof
|
|
CN101851220A
|
|
Isoprene flavonoid compound and application thereof
|
|
EP2045247A1
|
|
Compounds for the inhibition of histone deacetylase
|
|
AU2007216781A1
|
|
Compounds for the inhibition of histone deacetylase
|
|
TW200911230A
|
|
Compounds for the inhibition of histone deacetylase
|
